Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Inspire Veterinary Partners, Inc. Class A ( (IVP) ) just unveiled an update.
On December 18, 2025, Inspire Veterinary Partners, Inc. entered into a Cancellation and Exchange Agreement with Target Capital 1 LLC under which the company agreed to cancel $150,000 of principal outstanding under a June 10, 2025 promissory note in exchange for issuing 3,000,000 shares of its Class A common stock, valued at $0.05 per share. The private, exempt debt-for-equity swap reduces Inspire’s debt load while diluting existing shareholders, reflecting a balance-sheet-focused capital structure move that may improve liquidity and financial flexibility but alters the company’s ownership mix and could affect investor perceptions of its financing strategy.
The most recent analyst rating on (IVP) stock is a Sell with a $0.04 price target. To see the full list of analyst forecasts on Inspire Veterinary Partners, Inc. Class A stock, see the IVP Stock Forecast page.
Spark’s Take on IVP Stock
According to Spark, TipRanks’ AI Analyst, IVP is a Underperform.
The score is weighed down primarily by weak financial performance (losses, leverage, and negative cash flow) and very bearish technicals (deeply below moving averages with negative momentum). Valuation provides limited support due to a non-meaningful negative P/E and no dividend, while Nasdaq delisting risk is an additional material negative factor.
To see Spark’s full report on IVP stock, click here.
More about Inspire Veterinary Partners, Inc. Class A
Inspire Veterinary Partners, Inc. operates in the veterinary services sector, focusing on owning and managing veterinary practices and related pet care services in the U.S. market.
Average Trading Volume: 38,328,991
Technical Sentiment Signal: Sell
Current Market Cap: $1.8M
Find detailed analytics on IVP stock on TipRanks’ Stock Analysis page.

